23/04/2026
We are excited to announce that a new Group Leader is joining IMol!
Please join us in welcoming Dr. Philipp Sondermann, who will head the Laboratory for Drug Evolution. This new laboratory will operate as a joint affiliation with the IOCB Prague - Institute of Organic Chemistry and Biochemistry, strengthening collaboration at the interface of chemistry and molecular biology.
Dr. Sondermann’s work focuses on innovative approaches to drug discovery and evolution, and his team will contribute to advancing cutting-edge research in therapeutic development.
We look forward to the impact this new laboratory will bring and to the collaborations it will inspire across the IMol and IOCB communities.
Welcome to IMol Philipp!